Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2–SP1–SAT1 axis
Divya Murthy,Kuldeep S. Attri,Surendra K. Shukla,Ravi Thakur,Nina V. Chaika,Chunbo He,Dezhen Wang,Kanupriya Jha,Aneesha Dasgupta,Ryan J. King,Scott E. Mulder,Joshua Souchek,Teklab Gebregiworgis,Vikant Rai,Rohit Patel,Tuo Hu,Sandeep Rana,Sai Sundeep Kollala,Camila Pacheco,Paul M. Grandgenett,Fang Yu,Vikas Kumar,Audrey J. Lazenby,Adrian R. Black,Susanna Ulhannan,Ajay Jain,Barish H. Edil,David L. Klinkebiel,Robert Powers,Amarnath Natarajan,Michael A. Hollingsworth,Kamiya Mehla,Quan Ly,Sarika Chaudhary,Rosa F. Hwang,Kathryn E. Wellen,Pankaj K. Singh
DOI: https://doi.org/10.1038/s41556-024-01372-4
IF: 21.3
2024-03-03
Nature Cell Biology
Abstract:The ability of tumour cells to thrive in harsh microenvironments depends on the utilization of nutrients available in the milieu. Here we show that pancreatic cancer-associated fibroblasts (CAFs) regulate tumour cell metabolism through the secretion of acetate, which can be blocked by silencing ATP citrate lyase (ACLY) in CAFs. We further show that acetyl-CoA synthetase short-chain family member 2 (ACSS2) channels the exogenous acetate to regulate the dynamic cancer epigenome and transcriptome, thereby facilitating cancer cell survival in an acidic microenvironment. Comparative H3K27ac ChIP–seq and RNA–seq analyses revealed alterations in polyamine homeostasis through regulation of SAT1 gene expression and enrichment of the SP1 -responsive signature. We identified acetate/ACSS2-mediated acetylation of SP1 at the lysine 19 residue that increased SP1 protein stability and transcriptional activity. Genetic or pharmacologic inhibition of the ACSS2–SP1–SAT1 axis diminished the tumour burden in mouse models. These results reveal that the metabolic flexibility imparted by the stroma-derived acetate enabled cancer cell survival under acidosis via the ACSS2–SP1–SAT1 axis.
cell biology